'outstanding IP chambers'
Legal 500 2008
'An incredibly good set for IP matters'.
Legal 500 2010
'A number of great IT and telecoms barristers.'
Legal 500 2010
'Top drawer IP set.'
Legal 500 2010
'Practical and helpful clerks" provide a "smooth and personable service.'
Chambers and Partners 2011
'8 New Square successfully parlays its renowned IP expertise into success in the IT sector.'
Chambers & Partners (Information Technology) 2009
'A veritable powerhouse of IP expertise'
Chambers and Partners 2011
'excellence on IT matters'
Legal 500 (Information Technology) 2010
'clerking team that exhibits 'perfect communication''
Legal 500 2008
Laboratorios Almirall SA -and- Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)
Case Summary | Judgment | 23 January 2009
Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other's patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held that both patents were invalid and should be revoked.